Poster

n. 1 - PROGNOSTIC VALUE OF DIVERGENT PATTERN DETECTION BY 99mTc-SESTAMIBI GATED SPECT FOR PREDICTING LEFT VENTRICULAR REMODELING IN PATIENTS WITH ANTERIOR ACUTE MYOCARDIAL INFARCTION
R. Calabretta, A. Castello, S. Nicolosi, C. Giglioli, G. Cerisano, R. Sciagrà
n. 2 - EVOLUTION FOR CARDIAC: RELEVANCE OF RECONSTRUCTION VOI IN SEMI-QUANTITATIVE IMAGING
A. Odolini, L. Federici, D. Scalvini, F. Motta, C. Rodella, R. Giubbini, L. Camoni
n. 3 - CZT-CAMERA VS DUAL-HEADED ANGER CAMERA WITH RESOLUTION RECOVERY: A COMPARISON OF SEMIQUANTITATIVE MYOCARDIAL PERFUSION AND FUNCTIONAL PARAMETERS
I. Burchert, F. Caobelli, T. Wollenweber, C. Dieckmann, J. Fulsche, M. Nierada, F.M. Bengel
n. 4 - DIAGNOSTIC ACCURACY OF CZT-BASED MYOCARDIAL PERFUSION SPECT: IMPACT OF ATTENUATION CORRECTION USING A CO-REGISTERED EXTERNAL CT
F. Caobelli, M. Akin, T. Brunckhorst, J. Thackeray, J. Widder, G. Berding, J. Bauersachs, F.M. Bengel
n. 5 - FEASIBILITY OF AN EIGHTH-TIME GATED MYOCARDIAL PERFUSION SPECT FUNCTIONAL IMAGING USING IQ-SPECT SYSTEM
F. Caobelli, A. Soffientini, F.M. Bengel, C. Pizzocaro, U.P. Guerra
n. 6 - CAN MYOCARDIAL SALVAGE INDEX ASSESSED BY GATED SPECT PLAY A ROLE FOR PREDICTING THE FUNCTIONAL OUTCOME OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION?
A. Castello, R. Calabretta, C. Giglioli, R. Sciagrà
n. 7 - ROLE OF LONG-LASTING LEFT VENTRICULAR DYSFUNCTION ASSESSED BY STRESS GATED MYOCARDIAL PERFUSION SCINTIGRAPHY IN THE EVALUATION OF CORONARY ARTERY DISEASE SEVERITY
C. Cittanti, E. Succi Leonelli, F. Ferrari, C. Peterle, I. Santi, S. Panareo, V. De Cristofaro, L. Uccelli, L.M. Feggi
n. 8 - REDUCTION OF RADIATION EXPOSURE DURING SPECT/CT MYOCARDIAL PERFUSION IMAGING: CAN A SINGLE CT SCAN BE USED FOR ATTENUATION CORRECTION OF STRESS-REST STUDIES?
V. Fiore, V. Gasparetto, L. Gallo, E. Milan
n. 9 - I123-MIBG PROGNOSTIC VALUE IN A SELECTED PATIENTS POPULATION WITH IDIOPATHIC CARDIOMYOPATHY CANDIDATE TO AICD IMPLANT: UPDATE OF A PILOT STUDY
G. Bertuccio, G. Scrima, G. Canavese
n. 10 - 123I-MIBG SCAN IN DECISION MAKING OF ICD IMPLANTATION IN HEART FAILURE PATIENTS: A SINGLE CENTER EXPERIENCE
V. Frantellizzi, G. De Vincentis, T. Garkavaya, G.A. Follacchio, N. Rinvenuto, S. Iacobelli, F. Monteleone, M. Liberatore, A. Farcomeni, N. Salvi, P. Scarparo, C. Calvieri, F. Fedele
n. 11 - IMPACT OF PRONE-POSITION ACQUISITION OF 123I-MIBG CARDIAC IMAGING ON HEART-TO-MEDIASTINUM RATIO
T. Pellegrino, A. Boemio, V. Piscopo, R. Carotenuto, B. Russo, S. Pellegrino, G. De Matteis, A. Cuocolo
n. 12 - SLEEP-DISORDERED BREATHING IS ASSOCIATED WITH IMPAIRED CARDIAC SYMPATHETIC INNERVATION AND PREDICT PROGNOSIS IN PATIENTS WITH HEART FAILURE
T. Pellegrino, S. Paolillo, V. Piscopo, A. Boemio, R. Carotenuto, B. Russo, S. Pellegrino, G. De Matteis, P. Perrone Filardi, A. Cuocolo
n. 13 - NON INVASIVE DETECTION OF ARRHYTHMOGENIC MYOCARDIUM
R. Pirisino, P. Pizzichini, M. Tuccimei, C. Cottignoli, A. Lenza, L. Antonini, F. Scopinaro
n. 14 - IMPACT OF DIABETES MELLITUS AND ISCHEMIC CARDIOMYOPATHY ON CARDIAC SYMPATHETIC INNERVATION IN PATIENTS WITH HEART FAILURE
V. Piscopo, T. Pellegrino, A. Boemio, R. Carotenuto, B. Russo, S. Pellegrino, G. De Matteis, M. Petretta, A. Cuocolo
n. 15 - 99MTC-DPD IN AMYLOIDOTIC CARDIOMIOPATHY
F.E. Buroni, M.G. Persico, L. Lodola, C. Aprile
n. 16 - ROLE OF FDG-PET/CT FOR ASSESSMENT OF DISEASE ACTIVITY IN PATIENTS WITH TAKAYASU ARTERITIS
E. Incerti, E. Tombetti, F. Fallanca, E. Baldissera, P. Alongi, A. Manfredi, M.G. Sabbadini, L. Gianolli, M. Picchio
n. 17 - COMPARISON AMONG DIFFERENT GATED MYOCARDIAL PERFUSION SOFTWARE AND ECHOCARDIOGRAPHY IN MEASURING THE LEFT VENTRICULAR EJECTION FRACTION
A. Di Palo, A. Niccoli Asabella, C. Ferrari, A. Notaristefano, V. Loseto, C. Magarelli, G. Rubini
n. 18 - FOURIER ANALYSIS-DERIVED PARAMETERS IN CARDIAC RESYNCHRONIZATION THERAPY FOR CONGESTIVE HEART FAILURE: A 8-YEAR FOLLOW UP
D. Pontillo, A. Ricci, S. Trivisonne, F. Fiore Melacrinis, S. Maccafeo, P.A. Chiavari, L. Chiatti, R. Schiavo
n. 19 - 18F-FDG PET/CT IN OCULAR AND ORBITAL ABNORMALITIES: COMPARISON WITH TRADITIONAL MORPHOLOGICAL IMAGING
C. Altini, A. Niccoli Asabella, C. Ferrari, E.P. Mossa, N. Merenda, A. Di Palo, G. Rubini
n. 20 - THE ROLE OF FDG-PET/CT IN PATIENTS WITH LOCALLY ADVANCED OROPHARYNGEAL CANCER UNDERGOING TOMOTHERAPY WITH DOSE ESCALATION
M. Kirienko, I. Dell’oca, E. Incerti, C. Fiorino, P. Alongi, S. Broggi, A. Chiara, N. Di Muzio, L. Gianolli, M. Picchio
n. 21 - CAN WE USE THE PET/CT IMAGING FOR LOCAL STAGING IN ADVANCED GLOTTIC CANCER? CLINICAL IMPACT AND COMPARISON WITH CONVENTIONAL IMAGING
G. Paone, G. Treglia, T. Ruberto, L. Ceriani, L. Giovanella
n. 22 - PET CLINICAL VALUE FOR TUMOR RESPONSE TO PLATINUM-BASED THERAPY
G. Banna, A. Stefano, N. Porcino, G. Russo, D. D’Urso, V. Mocciaro, S. Gieri, G. Anile, S. Cosentino, G. Murè, S. Baldari, M.G. Sabini, D. Sardina, F. Fraggetta, M.C. Gilardi, M. Ippolito
n. 23 - DUAL POINT FDG-PET/CT IN CHARACTERIZATION OF LUNG LESIONS: IS IT ALWAYS WORTHWHILE?
E. Borsatti, N. Papais, E. Bidoli, T. Baresic, M. Di Fant, G. Rallo, C. Zilio, F. Mazza
n. 24 - F-18 FDG-PET/CT PARAMETERS AS PREDICTORS OF OUTCOME IN NON SURGICAL NSCLC PATIENTS
D. Capacchione, A. Nappi, R. Gallicchio, S. Giacomobono, A. Venetucci, A. Nardelli, A. Pelagalli, A. Della Morte, D. Marasco, N. D’Errico, F. Volpicelli, G. Storto
n. 25 - POSITRON EMISSION TOMOGRAPHY CT TO DIFFERENTIATE TUMOR RECURRENCE AND RADIATION-INDUCED PULMONARY FIBROSIS AFTER STEREOTACTIC BODY RADIATION THERAPY
G. Capriotti, S. Di Traglia, A. Covello, P. Pizzichini, D. Prosperi, M. Tuccimei, R. Maurizi Enrici, M.F. Osti, F. Scopinaro
n. 26 - WHAT IS THE PROGNOSTIC VALUE BY THE COMBINATION OF MORPHOLOGICAL AND METABOLIC DATA IN LUNG CANCER PATIENTS? A COMPLEMENTARY STUDY OF CT AND PET/CT
L. Evangelista, A.R. Cervino, A. Panunzio, E. Scagliori, R. Polverosi, P. Fabio, G. Saladini
n. 27 - PREDICTIVE VALUE OF 18F-FDG PET/CT SUVMAX IN STAGE I ADENOCARCINOMA OF THE LUNG AND CORRELATION WITH HISTOLOGICAL SUBTYPE AND SICA-TRAVIS SCORE*
F. Orsini, O. Rena, E. Puta, L. Leva, R. Boldorini, C. Casadio, G.M. Sacchetti
n. 28 - PROGNOSTIC ROLE OF 18F-PET/CT SUVMAX IN PATIENTS WITH COLORECTAL LUNG METASTASIS SUBMITTED TO SURGICAL RESECTION
F. Orsini, O. Rena, E. Puta, L. Leva, E. Papalia, C. Casadio, G.M. Sacchetti
n. 29 - THE UNDETERMINED SOLITARY PULMONARY NODULE: 18F-FDG DIAGNOSTIC PERFORMANCE IN 368 NON-ONCOLOGICAL SUBJECTS
S. Taralli, M.L. Calcagni, G. Cardillo, P. Graziano, P. Ialongo, M.V. Mattoli, D. Di Franco, C. Caldarella, F. Carleo, L. Indovina, A. Giordano
n. 30 - METABOLIC AND ANATOMIC CRITERIA USE IN EVALUATION OF ERLOTINIB TREATMENT RESPONSE
A. Stefano, H. Soto Parra, G. Russo, D. D’Urso, S. Cosentin, G. Murè, S. Baldari, M.G. Sabini, D. Sardina, L.M. Valastro, R. Bordonaro, C. Messa, M.C. Gilardi, M. Ippolito
n. 31 - EVALUATION OF MONOAMINE VESCICULAR TRANSPORTERS IN PARASYMPATHETIC AND SYMPATHETIC PARAGANGLIOMAS
S. Chiacchio, A. Bacca, A. Pucci, C. Congregati, V. Duce, F. Basolo, F. Betti, G. Manca, G. Boni, S. Mazzarri, G. Mariani, G. Bernini, D. Volterrani
n. 32 - PHYSIOLOGICAL JOINT PITFALL AND MISINTERPRETATION OF PET/CT DOPA SCAN
A.R. Cervino, L. Evangelista, M. Burei, G. Saladini
n. 33 - 111IN-PENTETREOTIDE SPECT/CT IN NEUROENDOCRINE TUMOR (NETS) DIAGNOSTIC MANAGEMENT
A. Spanu, G. Madeddu, O. Scillaci, B. Piras, A. Falchi, R. Danieli, P. Ferro, I. Gelo, F. Dore, S. Nuvoli
n. 34 - 99MTC-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS AN USEFUL AND COST-EFFECTIVE TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC)
L. Giovanella, S. Giovinazzo, F. Di Mauro, S. Pignata, E. Amato, M.E. Stipo, M. Siracusa, M.R. Ruggeri, S. Baldari, A. Campennì
n. 35 - A PROSPECTIVE TRIAL FOR THE EVALUATION OF ESOPHAGEAL CANCER PATIENTS: FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) VS. CONTRAST ENHANCEMENT (C.E.)CT VS. FDG PET/C.E.CT
A.R. Cervino, L. Evangelista, F. Pomerri, E. Scagliori, R. Alfieri, C. Castoro, A. Ruol, S. Galuppo, V. Chiarion Sileni, G. Saladini
n. 36 - PROGNOSTIC SIGNIFICANCE OF PET/CT TOTAL LESION GLYCOLYSIS IN PATIENTS WITH LOCALLY ADVANCED OESOPHAGEAL CANCER UNDERGOING NEOADJUVANT CHEMORADIOTHERAPY
D. Genovesi, G. Pallabazzer, E. Filidei, B. Solito, A. Bottoni, M. Lencioni, M.G. Fabrini, P. Marzullo, S. Santi, A. Giorgetti
n. 37 - THE ADDITIONAL VALUE OF 18F-FDG PET/CT IN EVALUATION OF PATIENTS WITH CHOLANGIOCARCINOMA AFTER THERAPY
P. Ghedini, H. Svirydenka, E. Tabacchi, S. Diodato, P. Coppolino, M. Celli, A.O. Rabines J., P. Castellucci, S. Fanti
n. 38 - THE ROLE OF DOUBLE TRACER PET/CT IN COMPARISON WITH CI IN EVALUATING PATIENTS WITH HCC: PRELIMINARY RESULTS
I. Grassi, C. Fonti, A. Gianstefani, A. Pecorelli, P. Ghedini, P. Castellucci, R. Golfieri, L. BolondI, S. Fanti
n. 39 - EVALUATION OF HEPATOCELLULAR CARCINOMA PROGRESSION BY CORRELATION OF 18F-FDG PET/CT FINDINGS AND SERUM ALPHA FETOPROTEIN LEVELS
A. Notaristefano, A. Niccoli Asabella, C. Altini, F. Iuele, M. Fanelli, N. Merenda, G. Rubini
n. 40 - COULD C.E. CT/PET WITH 18F-FDG REPRESENT THE ONLY EXAMINATION IN RECTUM ADENOCARCINOMA STAGING?
D. Penna, J.R. García, P. Arace, E. Llinares, V. Arena, E. Riera, E. Pelosi
n. 41 - EVALUATION OF RECURRENT DISEASE IN THE RE-STAGING OF COLORECTAL CANCER BY 18F FDG PET/CT: CAN CEA AND CA 19.9 HELP IN PATIENT SELECTION?
A. Fiorentini, D. Rinino, A. Chiaravalloti, D. Di Biagio, A. Lacanfora, S. Pizzi, L. Travascio, O. Schillaci
n. 42 - 18F-FDG PET/CT IN FIRST DIAGNOSIS OF ENDOMETRIAL CANCER: COULD SUVMAX AND TBR, BOTH LIVER AND BLOOD-POOL, IDENTIFY PATIENTS AT HIGH RISK OF RECURRENCE?
M. Bertoli, F. Motta, D. Albano, A. Alkhraiheh, G. Bosio, R. Giubbini, F. Bertagna
n. 43 - ADDED VALUE OF RADIOLABELED CHOLINE PET/CT IN PATIENTS WITH PROSTATE CANCER TO IDENTIFY INCIDENTALOMAS
M. Sollini, F. Pasqualetti, R. Boni, M.G. Fabrini, E. Lazzeri, M. Roncali, S. Rubagotti, A. Versari, P.A. Erba
n. 44 - POTENTIAL CLINICAL USE OF DYNAMIC 11C-CHOLINE PET/CT FOR EVALUATION OF PROSTATE CANCER IN PATIENTS WITH LOCO-REGIONAL FAILURE CANDIDATES TO RADIOTHERAPY
P. Alongi, M. Spallino, E. Incerti, L. Gianolli, M. Picchio
n. 45 - THERAPY OF REFRACTORY METASTATIC PROSTATE (PC) CANCER PATIENT WITH 64CUCL2: A PRELIMINARY CASE REPORT OF CLINICAL EFFICACY
E. Capasso, S. Durzu, S. Piras, C. Meleddu
n. 46 - THE ROLE OF 18F-FLUOROCHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (FCH-PET/CT) IN EARLY RESPONSE ASSESSMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE ACETATE
P. Caroli, L. Fantini, U.F. De Giorgi, R. Galassi, A. Moretti, V. Mautone, E. Sintuzzi, D. Amadori, G. Paganelli, F. Matteucci
n. 47 - 18F-CHOLINE PET/CT IN PROSTATE CANCER PATIENTS: IS THE EARLY DYNAMIC ACQUISITION OF THE PELVIC REGION REALLY USEFUL?
L. Dellavedova, A. Vignati, L.S. Maffioli
n. 48 - LOCOREGIONAL RECURRENCE OF PROSTATE CANCER: ROLE OF DYNAMIC 18F CHOLINE PET/CT
D. Di Biagio, A. Chiaravalloti, A. Lacanfora, P. Abbatiello, F. Scalone, R. Catalano, M. Tavolozza, O. Schillaci
n. 49 - 18F-CHOLINE (FCH) PET/CT FOR STRATIFYING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RELAPSE
S. Giacomobono, R. Gallicchio, D. Capacchione, A. Venetucci, A. Nappi, T. Masciandaro, A. Di Leo, N. D’Errico, A. Piccolella, F. Volpicelli, A. Nardelli, T. Pellegrino, P. Mastrangelo, G. Storto
n. 50 - ROLE OF 11C ACETATE PET/CT IN PATIENTS WITH SUSPECTED RELAPSE OF PROSTATE CANCER
A. Sartorello, S. Bissoli, S. Medea, V. Fiore, E. Milan
n. 51 - IMPACT OF 18F CHOLINE PET AND MR ON THE ASSESSMENT OF RISK CLASS IN PROSTATE CANCER
M. Tuccimei, M. Valeriani, G. Argento, M.F. Osti, P. Bonome, R. Maurizi Enrici, F. Scopinaro
n. 52 - UPFRONT TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL) WITH ZEVALIN
L. Aloj, F. Frigeri, F. De Martinis, L. Mettivier, L. D’Ambrosio, G. Capobianco, A. Pinto, S. Lastoria
n. 53 - ROLE OF 18F-FDG PET/CT FOR EARLY POST-RADIOTHERAPY ASSESSMENT IN SOLITARY BONE PLASMACYTOMAS
P. Alongi, L. Zanoni, E. Incerti, F. Fallanca, N. Papathanasiou, L. Gianolli, M. Picchio, J. Bomanji
n. 54 - ROLE OF WB-MR/DWIBS COMPARED TO 18F-FDG PET/CT IN THE THERAPY RESPONSE ASSESSMENT OF LYMPHOMA
C. Ferrari, A. Niccoli Asabella, N. Maggialetti, C. Minoia, M. Fanelli, G. Loseto, A. Calabrese, A. Guarini, G. Rubini
n. 55 - VARIABILITY OF BLOOD-POOL AND LIVER 18F-FDG SUVS IN HL AND NHL PATIENTS
O. Geatti, F. Bonutti, F. Giacomuzzi, M. Rensi, D. Primossi
n. 56 - CORRELATION OF SEMIQUANTITATIVE PET PARAMETERS WITH THE NOVEL BIOMARKER ARGINASE-1 IN HODGKIN LYMPHOMA
A. Romano, A. Stefano, G. Russo, S. Cosentino, N.L. Parrinello, C. Vetro, P. La Cava, D. Tibullo, C. Giallongo, A. Chiarenza, A. Figuera, G. Motta, L. Caruso, V. Mocciaro, U. Consoli, M.C. Gilardi, F. Di Raimondo, M. Ippolito
n. 57 - COMPARISON BETWEEN FDG PET/CT AND CONTRAST-ENHANCED CT FOR THE EVALUATION OF T-CELL LYMPHOMA PATIENTS
C. Popescu, M. Kirienko, C. Rusconi, E. Meli, P. Ferro, G. Cusato, A. Vanzulli, C. Rossetti
n. 58 - HEART UP-TAKE OF 99mTc-HDP IN BONE SCAN
P. Santoro, I. Montemurro, L. Fattizzi, M. Monti, C. Nacherlilla, G. Calò - Gabrieli
n. 59 - MULTIMODAL IMAGING FOR PROTON TREATMENT PLANNING IN PRIMARY BRAIN TUMORS
G. Carbone, S. Agostini, U. Rozzanigo, D. Amelio, A. Palucci, A. Palermo, S. Vennarini, M. Erini, E. Bagatin, M. Amichetti, F. Chierichetti
n. 60 - STAGING OF LOCALLY ADVANCED BREAST CANCER AND THE PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY: COMPLEMENTARY ROLE OF SCINTIMAMMOGRAPHY AND 18F-FDG PET/CT
L. Evangelista, A.R. Cervino, S. Michieletto, T. Saibene, E. Orvieto, F. Bozza, C. Ghiotto, G. Saladini
n. 61 - THE ADDICTIONAL VALUE OF 18F-FDG PET/CT IN PRE- AND POST-OPERATIVE SETTING IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
L. Evangelista, A.R. Cervino, T. Saibene, S. Michieletto, E. Bezzon, F. Pomerri, F. Bozza, C. Ghiotto, G. Saladini
n. 62 - COULD WHOLE-BODY MAXIMUM STANDARDIZED UPTAKE VALUE AND METABOLIC TUMOR VOLUME BY 18F-FDG PET/CT FURTHER STRATIFY THE PROGNOSIS OF LOCALLY ADVANCED BREAST CANCER PATIENTS?
L. Evangelista, A.R. Cervino, C. Ghiotto, T. Saibene, S. Michieletto, F. Bozza, G. Saladini
n. 63 - HAS 18FDG PET/CT A ROLE IN BREAST CANCER STAGING?
D. Grigolato, F. Pellini, M. Zuffante, M. Cucca, M. Meniconi, E. Carmagnani, G. Pollini, M. Ferdeghini
n. 64 - DUAL TIME FDG PET/CT IN PRONE POSITION AND METABOLIC CORRELATION WITH MOLECULAR SUBTYPES AND PROGNOSTIC FACTORS IN BREAST CANCER
D. Grigolato, M.G. Giri, M. Meniconi, M. Cucca, E. Manfrin, E. Carmagnani, M. Zuffante, G. Pollini, M. Ferdeghini
n. 65 - IMAGE FUSION BETWEEN FDG PET/CT IN PRONE POSITION AND MR IN BREAST CANCER EVALUATION
D. Grigolato, G. Pollini, M. Cucca, M. Zuffante, M. Meniconi, E. Carmagnani, M. Barillari, M.G. Giri, E. Zivelonghi, C. Cavedon, R. Pozzi Mucelli, M. Ferdeghini
n. 66 - BREAST SCINTIGRAPHY WITH BREAST SPECIFIC GAMMA-CAMERA (BSGC) AND DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING (DCE-MRI) IN LOCAL STAGING AND TUMOR SIZE ASSESSMENT OF PRIMARY BREAST CANCER
I. Gelo, L. Mele, S. Contu, D. Sanna, F. Chessa, S. Nuvoli, G. Madeddu, A. Spanu
n. 67 - CLINICAL-DIAGNOSTIC MEANING OF MAMMARY UPTAKE ACCIDENTALLY DETECTED DURING 18F-FDG PET/CT (PET): COMPARISON BETWEEN RADIOLOGICAL IMAGING AND HISTOPATHOLOGY
S. Panareo, P. Carcoforo, S. Corcione, P. Querzoli, C. Cittanti, I. Santi, C. Peterle, V. De Cristofaro, P. Torricelli, L. Feggi
n. 68 - MANUAL FUSED SINGLE PHOTON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN NEUROBLASTOMA: A 3D VISION FOR A CLINICAL GUIDE OF A HETEROGENEOUS BEHAVIOR DISEASE WITHOUT AN HYBRID TOMOGRAPH
M. Pizzoferro, M.F. Villani, M.A. De Ioris, R. Lombardi, E. Villanucci, A. Castellano, M.C. Garganese
n. 69 - 18F-FDG PET/CT IN THE ASSESSMENT OF CARCINOMA OF UNKNOWN PRIMARY ORIGIN: A MULTICENTRIC STUDY
M. Rossi, A. Romeo, M. Della Porta, F. Malvaldi, D. Bacciardi, R. Pratali, S. Stefanini, N. Mazzuca
n. 70 - INCIDENTAL 18F-FLUORODEOXYGLUCOSE FOCI IN THE LUNG PARENCHYMA IN THE ABSENCE OF ABNORMAL CT FINDINGS: OUR EXPERIENCE
M. Rossi, M. Della Porta, I. Taddei, F. Malvaldi, D. Bacciardi, R. Pratali, N. Mazzuca
n. 71 - FDG-PET/CT IN BREAST CANCER: IS IT USEFULL TO STAGE PATIENTS OR TO PREDICT DISEASE-FREE SURVIVAL?
M. Sollini, Z. Barbara, L. Calabrese, M.L. Di Paolo, A. Versari, M. Gasparini
n. 72 - FDG AND AMYLOID PET IN VIVO BIOMARKERS FOR THE PREDICTION OF MCI PROGRESSION
P. Alongi, C. Cerami, L. Iaccarino, A. Marcone, V. Bettinardi, S. Iannaccone, S. Cappa, D. Perani
n. 73 - CARDIAC ADRENERGIC DENERVATION ON TWO SEQUENTIAL 123I-MIBG MYOCARDIAL SCAN IN A CASE OF UNCERTAIN PARKINSONISM
B. Paghera, M. Bertoli, F. Motta, A. Peli, F. Caobelli, U.P. Guerra, R. Giubbini
n. 74 - PHENOTYPIC HETEROGENEITY OF NIEMANN-PICK DISEASE TYPE C IN MONOZYGOTIC TWINS
B. Paghera, M. Bertoli, F. Motta, V. Zilioli, E. Premi, A. Padovani, B. Borroni, R. Giubbini
n. 75 - FUNCTIONAL CORRELATES OF T-TAU, P-TAU AND Aβ1-42 AMYLOID CSF LEVELS IN ALZHEIMER’S DISEASE: A 18F FDG PET/CT STUDY
A. Chiaravalloti, A. Martorana, G. Koch, S. Toniolo, D. Di Biagio, B. Di Pietro, O. Schillaci
n. 76 - DOPAMINE TRANSPORTER AVAILABILITY IN GAMBLING DISORDER: PRELIMINARY 123I-FP-CIT SPECT RESULTS
D. Di Giuda, F. Cocciolillo, M. Zollino, M. Pettorruso, G. Camardese, G. Conte, L. Janiri, A. Giordano
n. 77 - CT-BASED ATTENUATION CORRECTION COMPARED TO CHANG’S METHOD FOR SEMIQUANTITATIVE EVALUATION OF 123I FP CIT SPECT STUDIES
M.C. Gaeta, E. Giovannini, E. Carabelli, E. Schirinzi, M. Del Sette, A. Ciarmiello
n. 78 - FP-CIT ACTIVITY NORMALIZATION IN SPM ANALYSIS. THE (REPRODUCIBLE) RELATIVITY IN GENDER COMPARISON
A. Galati, M. Manfredi, V. Garbaccio, E. Pilati, V. Liberini, G. Castellano, G. Bisi
n. 79 - CARDIAC MIBG SCINTIGRAPHY IN DIFFERENTIATION OF PARKINSON’S DISEASE AND ATYPICAL PARKINSONIMS: OUR EXPERIENCE
S. Grimaldi, M. Balma, A. Tarallo, M. Manfredi, M. Zotta, A. Romagnolo, M. Zibetti, G. Castellano, G. Bisi
n. 80 - RELATIONSHIP BETWEEN FREEZING OF GAIT AND FALLS IN PARKINSON’S DISEASE AND DOPAMINERGIC DISFUNCTION
F. Guidoccio, R. Ceravolo, D. Frosini, G. Puccini, U. Bonuccelli, I. Paglianiti, G. Manca, D. Volterrani
n. 81 - MOLECULAR SCREENING OF DYSTONIA GENES IN PATIENTS WITHOUT DOPAMINERGIC DEFICIT (SWEDDS): A NEW PATHOGENIC MUTATION IN THE DYT11 GENE
G. Marotta, B. Garavaglia, R. Cilia, C. Reale, A. Castagna, A. Nasca, M. Muzi-Falconi, C. Barzaghi, A. Marzegan, M. Granada, G. Sacilotto, D. Vallauri, G. Pezzoli, S. Goldwurm
n. 82 - REVERSIBLE DOPAMINE TRANSPORTER REDUCTION IN DRUG-INDUCED PARKINSONISM
G. Marotta, R. Cilia, A. Belletti, C. Siri, G. Pezzoli
n. 83 - NICOTINIC ACETYLCHOLINE RECEPTOR DENSITY IN COGNITIVELY INTACT SUBJECTS AT AN EARLY STAGE OF PARKINSON’S DISEASE
G. Marotta, I.U. Isaias, J. Spiegel, J. Brumberg, K.P. Cosgrove, N. Oishi, H. Takahiro, S. Kusters, M. Schiller, U. Dillmann, C. Van Dick, A. Buck, K. Herrmann, S. Schloegl, J. Volkmann, M. Lassmann, K. Fassbender, R. LorenZ, S. Samnick
n. 84 - RANDOM FOREST CLASSIFIER CONTRIBUTION IN THE DIFFERENTIAL DIAGNOSIS OF MOVEMENT DISORDERS STUDIED BY 123I MIBG CARDIAC SCINTIGRAPHY
S. Nuvoli, B. Palumbo, F. Pompili, M.L. Fravolini, I. Sabalich, G. Dachena, A. Spanu, G. Madeddu
n. 85 - CUT-OFF VALUES OF 123I-MIBG CARDIAC SCINTIGRAPHY DATA AS PROVIDED BY CLASSIFICATION TREE CLASSIFIER FOR THE DIFFERENTIAL DIAGNOSIS BETWEEN PARKINSON’S DISEASE AND PARKINSONISMS
S. Nuvoli, B. Palumbo, M.L. Fravolini, S. Cascianelli, T. Buresta, G. Dachena, B. Piras, A. Spanu, G. Madeddu
n. 86 - 123I-DAT-SCAN: A PROPOSAL TO AVOID INAPPROPRIATE INVESTIGATIONS.
M. Povolato, G. Ferretti, M. Rensi, E. Belgrado, R. Eleopra, O. Geatti
n. 87 - ASSOCIATION BETWEEN 123I-FP-CIT SPECT AND COGNITIVE OUTCOME IN PARKINSON’S DISEASE: A LONGITUDINAL STUDY AT 5 YEARS OF FOLLOW-UP
G. Puccini, R. Ceravolo, D. Frosini, F. Guidoccio, U. Bonuccelli, S. Chiacchio, G. Manca, D. Volterrani
n. 88 - THE BRAIN PERFUSION SPECT WITH 99mTc-HMPAO IN THE FOLLOW-UP OF PATIENTS WITH AUTOIMMUNE VASCULITIS
L. Turchetta, M.C. Ullo, S. Di Giovanni, M. Morreale, A. Francia, G. De Vincentis, F. Monteleone, M. Liberatore
n. 89 - BILATERAL HYPERMETABOLISM IN POSTERIOR CINGULUM AND PRECUNEUS IN SUBSTANCE-INDUCED PSYCHOSIS VERSUS SCHIZOPHRENIA
G. Marotta, F. Dragogna, M. Mauri, F.T. Armao, P. Brambilla, A.C. Altamura
n. 90 - SCINTIGRAPHIC FUNCTIONAL EVALUATION OF INTRATHECAL DRUG INFUSION DEVICES
G. Garraffa, V. Scaglione, F. Felice, R. Ricapito, I.T. Liotta, V. Azzarello, P. Cuntuliano, M. Giacalone, G. Arnone
n. 91 - MULTIMODAL NUCLEAR MEDICINE APPROACH IN THE WORK-UP OF INFANTS AND CHILDREN WITH AN HIGH URINARY TRACT INFECTION
M.R. Castellani, M. Testoni, G. Selvaggio, M. Maccauro, G. Aliberti, F. Crippa, A. Lorenzoni, G. Riccipetitoni
n. 92 - MONOINSTITUTIONAL EXPERIENCE OF A LONG LASTING FOLLOW-UP WITH MAG3- SCINTIGRAPHY IN CHILDREN WITH UPPER TRACT DILATATION
M.R. Castellani, G. Selvaggio, M. Maccauro, G. Aliberti, A. Lorenzoni, F. Crippa, G. Riccipetitoni
n. 93 - AN INTEGRATED WORK-UP TO UNDERSTAND THE CLINICAL MEANING OF POOR DRAINAGE AFTER PEDIATRIC PYELOPLASTY
M. Pizzoferro, M.F. Villani, E. Mele, G. Torino, S. Chiapparelli, N. Capozza, M.C. Garganese
n. 94 - COMPARISON OF 18F-DOPA PET/CT AND 123 I-MIBG SPECT IN NEUROBLASTOMA PEDIATRIC PATIENT
F. Tamburini, E. Binotti, V. Montesi, C. Nanni, S. Fanti
n. 95 - BONE SCAN IN CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS: A SIMPLE AND USEFUL TOOL FOR A RARE CHILDREN DISEASE
M.F. Villani, L. Tanturri De Horatio, M. Pizzoferro, A. Insalac, E. Villanucci, M.C. Garganese
n. 96 - SIOPEN SEMI-QUANTITATIVE SCORING SYSTEMS FOR NB IN123I-MIBG VS MR-DWIBS SEQUENCE
A. Castello, A. Perrone, A. Kokomani, D. Salpietro, F. Catalani, C. De Filippi, S. Nicolosi, C. Olianti
n. 97 - PEDIATRIC HODGKIN LYMPHOMA: VISUAL AND SEMIQUANTITATIVE ANALYSIS OF INTERIM 18FDG-PET/CT IN PREDICTING TREATMENT RESPONSE AND OUTCOME
C. Ferrari, A. Niccoli Asabella, M. Fanelli, N. Merenda, T. Perrillo, P. Muggeo, F. De Leonardis, N. Santoro, G. Rubini
n. 98 - A RARE CASE OF PEDIATRIC B-CELL LYMPHOBLASTIC LYMPHOMA WITH EXTENSIVE SKELETAL LESIONS
A. Kokomani, A. Tondo, P. Del Greco, R. Di Dato, H. Castagnoli, I. Laghai, A. Castello, C. Olianti
n. 99 - RETROSPECTIVE ANALYSIS OF IMAGING WITH 123I-MIBG IN CHILDREN AFFECTED BY NEUROBLASTOMA: ADDED VALUE OF SPECT/CT COMPARED WITH DIAGNOSTIC CT
V. Mattone, M. Casi, F. De Lauro, M. Agostini, S. De Vivo, M. Bartolomei
n. 100 - MIBG THYROID UPTAKE
R. Giubbini, R. Campini, E. Milan, C. Rodella, O. Zoccarato, F. Fracassi, L. Gallo, F. Motta, P. Barbara, F. Bertagna, C. Marcassa
n. 101 - 18F-CHOLINE PET/CT DETECTS HYPER-FUNCTIONING PARATHYROID TISSUE
I. Sonni, A. Tofani, S. Tetti, A. Bartolazzi, C. Bellotti, F. Scopinaro
n. 102 - DIFFERENT RECOVERY TIME FROM THE METABOLIC EFFECTS OF ACUTE HYPOTHYROIDISM USING TRIIODOTHYRONINE AND LEVOTHYROXINE
S. Di Traglia, A. Tofani, V. Di Rocco, R. Pirisino, A. Festa, M.L. Martini, P. Ragni, F. Scopinaro
n. 103 - INCIDENTAL UPTAKE OF 18F-FLUOROCHOLINE IN THE NECK: A NOVEL PET TRACER FOR PARATHYROID ADENOMA?
S. Chiacchio, M. Tredici, S. Mazzarri, M. Grosso, G. Manca, G. Puccini, L. Antonacci, F. Betti, G. Boni, D. Volterrani
n. 104 - SALIVARY ABSOLUTE UPTAKE INDEX IN SJOGREN SYNDROME: A NEW EVALUATION OF FUNCTIONAL IMPAIRMENT
R. Di Dato, O. Djepaxhija, A. Kokomani, A. Castello, I. Laghai, C. Olianti
n. 105 - VALIDATION OF A SCINTIGRAPHIC TECHNIQUE FOR THE EVALUATION OF PATIENTS WITH GASTRIC PULL-UP ESOPHAGECTOMY
L. Pavanello, M. Zuffante, F. Sciumè, F. Longo, M. Ferdeghini
n. 106 - THE ROLE OF ORO-PHARYNGEAL-ESOPHAGEAL SCINTIGRAPHY IN THE EVALUATION OF THE SWALLOWING FUNCTION IN PATIENT WITH NASOPAHRYNX AND OROPHARYNX CANCER AFTER RADIOTHERAPY: SHORT-TERM RESULTS OF AN ONGOING PROSPECTIVE STUDY
G. Puccini, M. Grosso, E. Tardelli, E. Fiasconaro, S. Margotti, M. Gennaro, L. Locantore, F. Guidoccio, S. Ursino, B. Fattori, F. Matteucci, D. Volterrani
n. 107 - SCINTIGRAPHIC STUDY OF GASTRIC CONDUIT EMPTYING AFTER ESOPHAGECTOMY. HAS PYLOROPLASTY STILL A ROLE?
M. Zuffante, L. Gobbi, L. Pavanello, S. Giacopuzzi, J. Weindelmayer, F. Longo, C. Erica, M. Cucca, D. Grigolato, G. De Manzoni, M. Ferdeghini
n. 108 - PERFORMANCE OF LUNG PERFUSION SCINTIGRAPHY FOR EMBOLISM IN EMERGENCY SERVICE: OUR CENTER EXPERIENCE
A. Di Palo, A. Niccoli Asabella, C. Altini, C. Ferrari, C. Magarelli, M. Polito, G. Rubini
n. 109 - GFR ESTIMATION IN ELDERLY AND SARCOPENIC PATIENTS BY CREATININE-BASED FORMULAS AND BY 51CR-EDTA : A COMPARATIVE STUDY
G. Pietrapertosa, F. Placentino, P. Tabacco, M. Mangiacotti, A. Bruno, G. Valle, V. Frusciante
n. 110 - FDG-PET EVALUATION OF TAMOXIFEN THERAPY OF RETROPERITONEAL FIBROSIS: A CASE REPORT
M. Zotta, V. Garbaccio, E. Pilati, M. Manfredi, M. Bellò, G. Bisi
n. 111 - BONE AND JOINT PROSTHESIS INFECTION: COMPARISON BETWEEN TWO DAYS AND SINGLE DAY IMAGING ACQUISITION OF LABELLED LEUKOCYTES SCINTIGRAPHIES
R. Boni, P.A. Erba, M. Sollini, G. Cataldi, G. Mariani, E. Lazzeri
n. 112 - ROLE OF 18F-FDG PET/CT IN THE DIAGNOSIS OF STEROID-NAïVE LARGE-VESSEL VASCULITIS: ACCURACY OF VARIOUS SEMI-QUANTITATIVE PARAMETERS
L. Dellavedova, C. Songini, L.S. Maffioli
n. 113 - MALIGNANT OTITIS EXTERNA: CLINICAL ROLE OF 99MTC-HMPAO-WBC SPECT/CT
G. Garraffa, M. Caruso, A. Caruso, F. Felice, R. Ricapito, M.T. Arnone, G. Calsabianca, T.I. Liotta, V. Azzarello, P. Cuntuliano, M. Giacalone, G. Arnone
n. 114 - CLINICAL ROLE OF 99MTC-HMPAO-WBC SCINTIGRAPHY IN LOWER LIMB CHRONIC ULCERS
G. Garraffa, M.S. Aliquò, S. Giordano, F. Felice, R. Ricapito, M.T. Arnone, T.I. Liotta, V. Azzarello, P. Cuntuliano, M. Giacalone, G. Calsabianca, G. Arnone
n. 115 - THE UTILITY OF FDG PET/CT IN LEFT VENTRICULAR ASSIST DEVICE INFECTION
D. Grigolato, M. Merighi, E. Carmagnani, M. Cucca, M. Meniconi, M. Zuffante, A. Forni, E. Concia, M. Ferdeghini
n. 116 - ROLE OF 18F-FDG PET IN GUIDING TREATMENT OF PATIENTS WITH SARCOIDOSIS
E. Incerti, G. Cremona, A.M. Samanes Gajate, F. Fallanca, S. Dal Farra, P. Mapelli, L. Gianolli, M. Picchio
n. 117 - [18F]-FDG PET/CT AND INFECTION SITES DETECTION
V. Montesi, F. Tamburini, E. Binotti, F. Nanni, C. Nanni, S. Fanti
n. 118 - NANOCOLLOID SCAN AND GRANULOMATOUS INFECTION
F. Fiore Melacrinis, S. Chiusaroli, S. Maccafeo, A. Ricci, R. Schiavo
n. 119 - THE USE OF 99MTC-LABELLED LEUKOCYTE SCAN AND OPEN BIOPSY IN THE MANAGEMENT OF ORTHOPEDIC PROSTHESES INFECTION
M. Ullo, L. Turchetta, M. Caruso, G. De Vincentis, F. Monteleone, M. Liberatore
n. 120 - COMPARISON BETWEEN 18F-FDG PET/CT AND 99MTC-HMPAO SPECT/CT IN THE EVALUATION OF SUSPECTED OSTEOMYELITIS: EXPERIENCE IN 43 PATIENTS
P. Ferro, G. Cusato, C. Popescu, G. Cabrini, M. Milella, R. Sara, C. Rossetti
n. 121 - COMPARING FDG PET/CT AND WBC SCAN IN PATIENTS WITH AND WITHOUT SUSPICION OF VASCULAR GRAFT INFECTION
M. Pacilio, C. Lauri, F. Trapasso, I. Baldazzi, D. Prosperi, C. Tirotti, M. Taurino, F. Scopinaro, A. Signore
n. 122 - DETERMINATION BY ALGORITHM OF THE SENTINEL NODE DEPTH
G. Ascoli, D. Ulivi, S. D’ Onofrio, S. Di Domenicantonio, M. Morelli
n. 123 - INTRAOPERATIVE 99MTC-SESTAMIBI SCINTIGRAPHY WITH MINIATURE GAMMA CAMERA FOR RADIOGUIDED PARATHYROIDECTOMY: OUR EXPERIENCE
S. Castorina, G. Scerrino, M. Doronzo, I. Melfa, C. Lo Piccolo, C. Raspanti, R.P. Costa
n. 124 - USEFULNESS OF SPECT/CT FOR LYMPHATIC MAPPING IN BREAST CANCER SURGERY
G. Castriotta, M. Di Bari, L. Trotta, L. Ciuffreda, R. Murgo, V. Frusciante
n. 125 - SENTINEL LYMPH-NODE BIOPSY AND 18F-FDG PET/CT ACCURACY IN WOMEN WITH ADVANCED SQUAMOUS CARCINOMA OF THE VULVA: PRELIMINARY DATA OF PROSPECTIVE STUDY
A. Collarino, L. Zagaria, S.M. Fragomeni, G. Perotti, G. Garganese, P. Mirk, A. Stefanelli, M.T. Evangelista, G. Scambia, A. Giordano, V. Rufini
n. 126 - REAL-TIME RADIOISOTOPIC SYSTEMIC LEAKAGE MONITORING DURING HYPERTHERMIC ISOLATED LUNG PERFUSION WITH TNF-α
F. Fiz, E. Ferrari, M. Manitto, G. Cristina, A. Alloisio, P. Lorena, M. Cecilia, M. Baucknecht, S. Gianmario, R. Giovanni Battista, V. Giuseppe
n. 127 - SENTINEL NODE BIOPSY WITH DUAL INTRACERVICAL INJECTION IN LOW-RISK, EARLY STAGE ENDOMETRIAL CANCER: PRELIMINARY RESULTS
G.A. Follacchio, S. Iacobelli, V. Frantellizzi, G. De Vincentis, M. Liberatore, F. Monteleone
n. 128 - THE RELIABILITY OF SENTINEL NODE BIOPSY IN CLINICALLY NEGATIVE INGUINAL NODES PENILE SQUAMOUS CELL CARCINOMA: THE RESULTS OF A PROSPECTIVE STUDY.
A. Lorenzoni, M. Maccauro, M. Catanzaro, N. Nicolai, G. Aliberti, T. Torelli, E. Seregni, D. Biasoni, R. Salvioni, F. Crippa
n. 129 - THE ROLE OF RADIO-GUIDED SENTINEL NODE BIOPSY AND 18FDG-PET IN THE MANAGEMENT OF CUTANEOUS HEAD-NECK MELANOMA PATIENTS
M.A. Renna, A. Niccoli Asabella, V. Loseto, F. Iuele, F. Simone, G. Rubini
n. 130 - ROLL AND SNOLL IN BREAST CARCINOMA PATIENTS AFTER NEOADJUVANT CHEMOTHERAPY (NAC) TREATMENT
Maccafeo S., Chiusaroli S., Fiore Melacrinis F., Ghinassi S., Massari A., Moscetti L., Piccinetti A., Pofi E., Frittelli P., R. Schiavo
n. 131 - EVALUATION OF “ROLL-LIKE” PROCEDURE FOR MINIMALLY-INVASIVE RADIOGUIDED PARATHYROIDECTOMY (MIRP) IN HYPERPARATHYROIDISM (HPT)
I. Santi, P. Carcoforo, G. Trasforini, S. Panareo, C. Cittanti, V. De Cristofaro, C. Peterle, E. Degli Uberti, L.M. Feggi
n. 132 - EVALUATION OF SECONDARY AND PRIMARY LYMPHEDEMA BY COMBINED LYMPHOSCINTIGRAPHIC STUDIES OF SUPERFICIAL AND DEEP SYSTEM
G. Villa, C.C. Campisi, M. Pennone, E. Monteverde, M.T. Verardi, G. Ferrarazzo, M. Bauckneht, I. Calamia, G. Sambuceti
n. 133 - RADIO-GUIDED SENTINEL NODE BIOPSY (SNB) IN PATIENTS (PTS) WITH SECOND PRIMARY IPSILATERAL BREAST CANCER (SPIBC): IMPACT ON SURGICAL PLANNING
C. Peterle, C. Cittanti, V. De Cristofaro, P. Carcoforo, M. Portinari, I. Santi, S. Panareo, L. Feggi
n. 134 - PREOPERATIVE LYMPHOSCINTIGRAPHY IN RE-SENTINEL NODE EVALUATION IN BREAST CANCER RECURRENCE
G. Fiorillo, M. Bortul, G. Di Santo, P. Reccia, M. Urbani, F. Dore
n. 135 - OUR EXPERIENCE WITH A NEW INTRAOPERATIVE GAMMA CAMERA IN PATIENTS WITH BREAST CANCER AND CUTANEOUS MELANOMA
M.A. Renna, A. Niccoli Asabella, V. Loseto, F. Simone, D. Rubini, F. Iuele, G. Rubini
n. 136 - CHARACTERIZATION OF QUANTITATIVE PERFORMANCE OF HYBRID SPECT/CT SYSTEM FOR 177LU DOSIMETRY.
A. Sarnelli, V. D’errico, E. Mezzenga, M. D’arienzo, F. Matteucci, S. Severi, G. Paganelli
n. 137 - DIFFERENT POSITIONING OF THE UPPER ARMS IN WHOLE BODY FDG PET/CT: EVALUATION OF ARTIFACTS AND STRATEGIES TO REMOVE THEM
F. Sciumè, P. Laura, D. Grigolato, M. Zuffante, M. Ferdeghini
n. 138 - BRAIN 18F-FDG/PET: IMAGE PROCESSING WITH A DEDICATED ALGORITHM (3D-SSP), USING MATRIX WITH DIFFERENT RESOLUTION
L. Michelangeletti, F.M. Fringuelli, G. Pietrini, S. Luzzi, P. Chiaramida, G. Mazzoni, D. Ulivi
n. 139 - MYOCARDIAL BLOOD FLOW ESTIMATION WITH 13N-AMMONIA PET/CT: INFLUENCE OF RECONSTRUCTION SETTINGS.
E. Milan, A. Ferretti, E. Bolla, C. Rodella, S. Cotti, A. De Agostini, L. Camoni, L. Gallo
n. 140 - BRAIN 18F-FDG/PET: ACQUISITION OF IMAGES IN “LIST MODE” WITH NEXT REVISION OF DATA USING DIFFERENT SURVEY’S TIMES
G. Pietrini, F.M. Fringuelli, L. Michelangeletti, P. Chiaramida, G. Mazzoni, S. Luzzi
n. 141 - HOW TO CHECK ATTENUATION CORRECTION IN MYOCARDIAL PERFUSION IMAGING TO AVOID ARTIFACTS
F. Scalorbi, R.J. Egoue Mongoue, M.C. Schifano, P. Turco, R. Simeone, P. Zucchetta, F. Bui, S. Ave, D. Cecchin
n. 142 - 18F-FDG PET/CT AND OSIRIX TO CALCULATE VOLUME IN HYPERTHERMIC ISOLATED LIMB PERFUSION: A VALIDATION STUDY.
I. Schiorlin, G. Felloni, A. Negri, G. Lunardi, P. Zucchetta, V. Bodanza, F. Bui, C.R. Rossi, M. Rastrelli, D. Cecchin
n. 143 - QUANTITATIVE PET-CT RESPONSE IN SOLID TUMORS: COMPARISON OF STANDARDIZED UPTAKE VALUES DETERMINED BY BODY WEIGHT, LEAN BODY MASS AND BODY SURFACE AREA
R. Stoico, L. Della Vedova, P. Baruzzi, L. Maffioli
n. 144 - BEST METHOD TO EVALUATE THE BREAST IN PRONE POSITION WITH FDG PET/CT
L. Pavanello, D. Grigolato, F. Sciumè, M. Zuffante, M. Ferdeghini
n. 145 - ESTABLISHMENT OF LOCAL DIAGNOSTIC REFERENCE LEVELS FOR PET/CT SCANS WITH 68GA-DOTANOC
M. Ranaldo, G. Lucconi, F. Zagni, G. Cicoria, S. Fanti, M. Marengo
n. 146 - AN AUTOMATED ALGORITHM FOR LIVER RECOGNITION IN PET SCANS
E. Bertone, F. Bergesio, A. Terulla, G. Boretto, P. Cerello, E. Fiorina, S. Chauvie
n. 147 - STUDY ON OPTIMIZATION OF IMAGING WITH 223RA IMAGING USING THREE COLLIMATORS SETS
A. Corazza, G. Cicoria, F. Zagni, G. Lucconi, D. Pancaldi, M. Marengo
n. 148 - EFFECTIVENESS OF RADIOIODINE TREATMENT AFTER RECOMBINANT HUMAN THYROID-STIMULATING HORMONE IN LOW-RISK THYROID CANCER
D. Albano, V. Zilioli, A. Peli, F. Motta, A. Al Khraisheh, M. Bertoli, M.B. Panarotto, G.C. Magri, R. Giubbini
n. 149 - MIDDLE-TERM OUTCOME AND SAFETY OF HYPERTHYROID PATIENTS TREATED WITH CALCULATED ACTIVITY OF RADIOIODINE
A. Campennì, E. Amato, M. Murè, V. Gangemi, M. Bertia, M. Cucinotta, R.M. Ruggeri, S. Baldari
n. 150 - OUR EXPERIENCE WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY IN PATIENTS AFFECTED BY PULMONARY NEUROENDOCRINE TUMORS
F. Minutoli, M. Cucinotta, D. Cardile, L. Cassalia, M. Licari, A. Sindoni, S. Baldari
n. 151 - EVALUATION AT EACH CYCLE WITH 68GA-DOTATOC-PET/CT IN ADVANCED NEUROENDOCRINE TUMOURS TREATED WITH PRRT
V. De Biasi, M. Casali, A. Filice, F. Fioroni, M. Iori, A. Tartaglione, A. Frasoldati, A. Versari
n. 152 - USE OF 90YTTRIUM GLASS MICROSPHERES (THERASPHERE) FOR THE TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA IN A HIV+ LYMPHOPENIC PATIENT
L. Dellavedova, M. Carletto, L.S. Maffioli
n. 153 - RADIATION DOSIMETRY OF 18F-ETHILCHOLINE IN PROSTATE CANCER PATIENTS
M. Sollini, F. Fioroni, E. Grassi, P.A. Erba, M. Asti, M. Casali, A. Fraternali, M. Iori, A. Versari
n. 154 - A MODEL FOR OPTIMIZATION AND PERSONALISATION OF INJECTED ACTIVITY IN DIAGNOSTIC NUCLEAR MEDICINE
R. Visentin, S. Agostini, E. Bagatin, F. Laich, A. Palermo, D. Donner, A. Valentini, F. Chierichetti
n. 155 - RADIONUCLIDE VOXEL S VALUES FOR INTERNAL DOSIMETRY IN DIFFERENT TISSUES CALCULATED THROUGH GEANT4 AND MCNPX MONTE CARLO CODES
L. Auditore, E. Amato, A. Italiano, A. Campennì, F. Minutoli, S. Baldari
n. 156 - A MICRODOSIMETRIC MODEL OF SOLID TUMOUR MICROVASCULATURE FOR RADIOPHARMACEUTICALS LABELED WITH 223RA, 111IN, 131I AND 177LU
E. Amato, S. Leotta, A. Italiano, L. Auditore, R. Gentile, N. Quartuccio, S. Baldari
n. 157 - RADIOPROTECTION IMPACT OF RADIOIODINE THERAPY FOR HYPERTHYROIDISM AFTER A PATIENT SPECIFIC DOSIMETRIC STU
C. Canzi, V. Longari, M. Castellani, F. Zito, F. Voltini, R. Benti
n. 158 - RENAL FUNCTION EVALUATION IN PATIENTS UNDERGOING REPEATED PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
F. Minutoli, M. Cucinotta, G. Restifo Pecorella, D. Cardile, P. Coppolino, A. Sindoni, S. Baldari
n. 159 - AL18F LABELED NOTA-OCTREOTATE: LABELING AND IN VITRO CHARACTERIZATION
F. De Martinis, R. Farese, M. Malinconico, A. Morisco, S. Pastore, S. Zanotta, L. Aloj, S. Lastoria
n. 160 - SYNTHESIS AND EVALUATION OF DIFFERENT CHELATORS FOR MOLECULAR TARGETED PEPTIDES USING 68GA AS RADIONUCLIDE
G. Imperato, A. D’Angelo, D. Peruzzi, J. Amico, G. Boni, G. Mattiacci, M. Salgarello, G. Gorgoni
n. 161 - POTENTIAL EFFECT OF AMYLOID IMAGING ON DIAGNOSIS AND INTENDED MANAGEMENT OF PATIENTS WITH COGNITIVE DECLINE: IMPACT OF APPROPRIATE USE CRITERION
D. Grazia, P. Michael J, S. Andrew, L. Ming, H. Craig, A. Anupa K, M. Mark
n. 162 - PROGNOSTIC VALUE OF 18F-FLORBETAPIR SCAN: A 36-MONTH FOLLOW UP ANALYSIS USING ADNI DATA
L. Ming, P. Michael J, S. Andrew, J. Abhinay D, D. Michael D, M. Mark A, D. Grazia
n. 163 - FIRST SYNTEHSIS OF FLT AT CANNIZZARO HOSPITAL OF CATANIA
F. Scopelliti, P. Di Raimondo, G. Petralia, G. Benfatto, M.A. Pometti, P.D. Ingargiola, S. Cosentino, S. Baldari, G. Murè, M. Ippolito
n. 164 - THE ROLE OF THE RADIO-CHEMIST IN SETTING, CONTROL AND QUALITY ASSURANCE OF TECHNETIUM RADIOPHARMACEUTICALS IN A U.C. OF NUCLEAR MEDICINE
M. Mascia, I. Putaturo, A.D. Di Nicola, G. Camplone, C. Villano, E. Serafini, B. Lamonaca, M. Romoli, E. Morelli, R. Martocchia, V. De Francesco
n. 165 - STUDY FOR DEFINING FREQUENCY IN ROUTINE ANALYTICAL CONTROL IN RADIOLABELLING PROCESS
F. Ria, G. Albini, S. Battista, S. Valentino, R. Messere, P. Gandolfo, R. Armonino, S. Papa
n. 166 - ACQUISIZIONE 3D VERSUS 2D IN PET/TC
L. Frontino, F. Santarelli, S. Varchetta, L. Travascio
n. 167 - PLANNING MEDIA FILL TEST AND ENVIRONMENTAL CONTROLS IN FILLING OF POSITRON EMISSION TOMOGRAPHY (PET) DRUGS
A.L. Viglietti, A. Davit, G. Perlo, M. Longo, R. Giuliano, A. Biggi
n. 168 - IN VIVO EVALUATION OF NANOSTRUCTURED LIPID LABELLED WITH TC-99M
E. Esposito, A. Boschi, L. Ravani, R. Cortesi, M. Drechsler, P. Mariani, S. Moscatelli, C. Contado, G. Di Domenico, C. Nastruzzi, M. Giganti, M. Pasquali, P. Martini, L. Uccelli
n. 169 - IMPORTANCE OF RADIOPHARMACEUTICAL INCUBATION TIME: A STUDY OF THE RADIOCHEMICAL PURITY OF THE TECHNETIUM-LABELLED ALBUMIN NANOCOLLOID
M. Muratori, A. Spandonaro, D. Maranzana, O. Gandini, G. Cuccu, B. Greco, R. Reggio, H. Rouhanifar, R. Russo, M.P. Sumatra, L. Tommasi, D. Valentini, M.R. Zanaga, O. Testori, A. Muni
n. 170 - IN VITRO EVALUATION OF NOVEL IN-111 LABELED CXCR4 ANTAGONISTS
L. Aloj, M. Aurilio, A. Trotta, E. Squame, S. Santagata, G. Morelli, S. Scala
n. 171 - RADIONUCLIDIC PURITY ASSESSMENT FOR RA-223 CHLORIDE RADIOPHARMACEUTICAL
F. Zagni, G. Cicoria, A. Corazza, C. Malizia, M. Marengo
n. 172 - OPTIMIZATION AND PERSONALIZATION OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE
S. Agostini, R. Visentin, E. Bagatin, M. Asinari, A. Valentini, D. Donner, A. Palermo, F. Chierichetti
n. 173 - USE OF NEEDLEFREE CLOSED SYSTEM DEVICES IN THE RADIOLABELLED WHITE BLOOD CELLS (WBC) PROCEDURE
G. Perlo, A. Davit, A.L. Viglietti, A. Biggi
n. 174 - LEAN APPROACH TO IMPROVING PERFORMANCE AND EFFICIENCY IN A NUCLEAR MEDICINE DEPARTMENT: A NEW TOOL FOR RADIOPROTECTION
L. Burroni, J. Guercini, C. Bianciardi
n. 175 - DETERMINATION OF CALIBRATION FACTORS FOR 223RA FOR 3 DIFFERENT SURFACE CONTAMINATION MONITORING INSTRUMENTS
G. Cicoria, A. Corazza, F. Zagni, D. Pancaldi, C. Rossi, M. Marengo
n. 176 - ASSESSMENT OF RESIDUAL RADIOACTIVITY BY A COMPREHENSIVE WIRELESS, WEARABLE DEVICE IN PATIENTS UNDERGOING RADIONUCLIDE THERAPY HOSPITALIZED IN RESTRICTED AREAS: COMPARISON WITH THE RESULTS OF A HOME DEVICE
R. Gallicchio, S. Giacomobono, D. Capacchione, A. Venetucci, A. Nappi, D. Scapicchio, A. Nardelli, A. Pelagalli, R. Martino, M. Plaitano, A. Tempone, F. Leggiadro, P. Rifino, D. Larotonda, P. Pedicini, G. Storto
n. 177 - EXTENSIVE USE OF MONTE CARLO SIMULATION IN THE DESIGN OF A NEW PET CYCLOTRON FACILITY
A. Infantino, M. Marengo, G. Cicoria, F. Severi, G. Gorgoni, M. Salgarello
n. 178 - RADIATION PROTECTION HANDLING 223RA-XOFIGO: ARE THERE ANY SAFETY ISSUES DUE TO THE PRESENCE OF 219RN?
A. Infantino, G. Cicoria, S. Vichi, A. Corazza, M. Marengo
n. 179 - ASSESSMENT OF THE EXPOSURE TO IONIZING RADIATIONS IN RADIOLOGIC TECHNOLOGIST STUDENTS
M. Fanelli, A. Niccoli Asabella, C. Altini, A. Notaristefano, D. Rubini, N. Merenda, G. Rubini
n. 180 - A MONTE CARLO SIMULATION TO CALIBRATE AN AIR MONITORING SYSTEM EQUIPPED WITH NAI DETECTOR
A. Sarnelli, M. Negrini, V. D’errico, D. Bianchini, E. Mezzenga, M. Benassi
n. 181 - HEALTH WORKERS’ RADIOPROTECTION EVALUATION IN TREATMENT AND ASSISTANCE PHASES OF AN HCC PATIENT UNDERGONE YTTRIUM-90 RADIOEMBOLIZATION
R. Stoico, P. Baruzzi, M. Carletto, L. Maffioli
n. 182 - RISK ASSESSMENT IN THE TRANSPORTATION OF RADIOACTIVE MATERIAL IN THE AREA OF BOLOGNA
S. Vichi, A. Infantino, D. Pancaldi, D. Mostacci, M. Marengo
n. 183 - TRANSLATIONAL IMAGING IN DIAGNOSTIC WORKUP OF NEURODEGENERATIVE PARKINSONIAN SYNDROME
C. Paschetta, A. Skanjeti, F. Buttari, D. Gned, M. Iudicello, V. Podio
n. 184 - ARTEFACTUAL FOCAL PULMONARY 18F-FDG PET/CT UPTAKE IN ABSENCE OF CT FINDINGS: PREVALENCE AND INTERPRETATION CRITERIA
S. Chondrogiannis, M.C. Marzola, G. Grassetto, L. Rampin, A.M. Maffione, A. Zorzi, E. Milan, D. Rubello
n. 185 - NUCLEAR MEDICINE IN VETERINARY PRACTICE: PRELIMINARY EXPERIENCES AT AZ. POLO VETERINARIO DI LODI
D. De Zani, M. Longo, C. Pettinato, G. Ravasio, M. Di Giancamillo, D.D. Zani
n. 186 - MOLECULAR IMAGING FOR THE EVALUATION OF DRUG-RECEPTOR INTERACTIONS IN PSYCOACTIVE SUBSTANCES OF ABUSE
M. Pasquali, L. Uccelli, A. Boschi, A. Ossato, P. Martini, M. Giganti, G. Di Domenico, G. Pupillo, M. Marti
n. 187 - DOSE OPTMIZATION IN PEDIATRIC UROLOGICAL PROCEDURES
G. Aimar, E. Roberto, F. Bergesio, A. Terulla, P. Dutto, C. Fagliano, A. Biggi, S. Chauvie
n. 188 - RADIOCHEMICAL PURITY QUALITY ASSURANCE ACCORDING TO THE NBP CODE OF GOOD PRACTICE: RESULTS ON 966 SAMPLES DURING THE FIRST 20 MONTHS AND OPERATIVE IMPLICATIONS
A. Bassan, E. Tommasi, S. Zerboni, S. Cittadin, A. Massaro, G. Grassetto, M.C. Marzola, D. Rubello
n. 189 - ROLE OF TECHNOLOGISTS IN THE SOFTWARE IMPLEMENTATION ASTRIM FOR NBP IN THE PROCESS OF SYNTHESIS OF Y90 DOTATOC
N. Bartolini, G. Di Guilmi, G. Marchi, V. Mattone, M. Casi, F. De Lauro, M. Bartolomei
n. 190 - TECHNOLOGIST APPROACH TO THE PEDIATRIC PATIENT IN NM: PERHAPS, NOT EVERYONE KNOWS THAT .....
G. Clerici, C. De Caro
n. 191 - ROLE AND RELEVANCE OF NURSERY SUPPORT IN MANAGEMENT AND PREPARATION OF DIABETIC PATIENTS WHO NEEDS A FDG-PET
S. Copetti, O. Geatti
n. 192 - DYNAMIC 18F-FDG PET ACQUISITION IN LIVER DISEASE: A PILOT STUDY IN A SMALL PATIENT POPULATION
M. Zappalà, S. Zampieri, R. Sanco, E. Zaramella, M. Sinigaglia, G. Masiero, L. Memo, L. Evangelista
n. 193 - DYNAMIC 18F-FDG PET ACQUISITION IN LOCALLY ADVANCED BREAST CANCER
M. Sinigaglia, R. Sanco, M. Zappalà, S. Zampieri, E. Zaramella, G. Masiero, L. Memo, L. Evangelista
n. 194 - THE BEST WAY FOR GLYCAEMIA MEASUREMENT IN PATIENTS UNDERGOING 18F FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT)
E. Carpin, M. Trevisan, A. Biscotto, F. Lincetto, G. Saladini, L. Evangelista
n. 195 - THREE-PHASE PROTOCOL 18F-DOPA PET/CT IN PATIENTS WITH NEUROENDOCRINE TUMORS
R. Sanco, S. Zampieri, L. Memo, G. Masiero, E. Zaramella, M. Zappalà, L. Evangelista, G. Saladini
n. 196 - CARDIAC REST-STRESS GATED SPECT ACQUISITION PROTOCOL: 8 VS 16 FRAMES/CYCLE QUANTITATIVE EVALUATION.
G. Givoli, G. Regolo, R. Stoico, G. Gianduia, L.F. Dellavedova, A. Vignati, L. Maffioli
n. 197 - QUALITATIVE AND QUANTITATIVE ANALYSIS OF 123I- DATSCAN SPECT IN THE DIAGNOSIS OF PARKINSON’S DISEASES: BODY-CONTOURING VERSUS CIRCULAR ORBIT ACQUISITION
A. Palmieri, A. Zocco
n. 198 - RADIOPHARMACEUTICALS PRODUCTION: VALIDATION PROCESS APPLICATION
S. Romani, L. Lodi, L. Uccelli, D. Farina, S. Bertelli, D. Bortolotti, E. Govoni, S. Zaccaria, E. Zappaterra, C. Cittanti, L. Feggi
n. 199 - PSF RECONSTRUCTION ALGORITHM IN PET/CT: PERFORMANCE EVALUATION AND OPTIMIZATION OF THE RECONSTRUCTION PARAMETERS
M.A. Rossato, A. Negri, M. Paiusco
n. 200 - PET IMAGING PROTOCOL VARIATIONS IN CLINICAL PRACTICE
P. Sebastiano, F. Bergesio, A. Terulla, E. Roberto, C. Fagliano, P. Dutto, A. Biggi, S. Chauvie
n. 201 - OPTIMIZATION OF THE ACQUISITION PROTOCOL OF 18F-FDG PET/CT IN ORDER TO AMELIORATE ITS DIAGNOSTIC ACCURACY IN THE ABDOMEN
E. Tommasi, S. Chondrogiannis, A. Bassan, A. Zorzi, L. Pavan, M.C. Marzola, E. Milan, C. Secchiero, D. Rubello
n. 202 - TECHNICAL CONSIDERATIONS PRECEDING THE SETUP OF AN ACQUISITION PROTOCOL FOR IN VIVO IMAGING OF 223RA-DICHLORIDE
L. Virdichizzi, F. Betti, L. Antonacci, F. Di Martino, D. Volterrani
n. 500 - titolo
Marco Gazzarrini